Podcast: This Week in Managed Care—Senate Confirms Azar and Other Health News

The executive order targets lower drug prices through Medicare reforms, anticompetitive crackdowns, and transparency mandates.

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

In 2021, UnitedHealth Group received 42% of the $33 billion in additional Medicare Advantage payments from differential coding.

On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.

Prior authorizations create substantial administrative and financial burdens on physicians and patients and can disrupt the continuity of care.

Best practices can help MA plans improve their Star Ratings performance while allow for strategies for medication adherence to grow.